Actinium Pharmaceuticals, Inc. (ATNM)

Cost of Revenue

-$395.00K

TTM · Period ending: · USD

ATNM logo

ATNM Cost of Revenue

Latest reported-$395.00K
ATNM Cost of Revenue ($0.00 → -$395.00K)
High-resolution chart · PNG

ATNM cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
0
811,000
0
0
524,000
447,000
420,089
50,721
55,938
77,523
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.